EUPRAXIA PHARMACEUTICALS INC. (EPRX) reporting calendar
EUPRAXIA PHARMACEUTICALS INC. files periodic reports with the SEC as EPRX on Nasdaq. Atlas tracks 3 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 40-F
- Period ended
- 31 Dec 2025
- Filed
- 13 Mar 2026
- Reports on record
- 3
Open EPRX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 40-F | 31 Dec 2025 | 13 Mar 2026 | 72 days | 0001193125-26-104765 |
| 40-F | 31 Dec 2024 | 20 Mar 2025 | 79 days | 0001193125-25-059352 |
| 40-F | 31 Dec 2023 | 1 Apr 2024 | 92 days | 0001193125-24-083584 |
Source: SEC EDGAR company submissions for CIK 0001581178. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.